Search Results - "Orlando, Sonia"
-
1
-
2
Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial
Published in Leukemia & lymphoma (03-07-2017)“…The activity and safety of a regimen combining lenalidomide with fludarabine and cyclophosphamide (FC) was investigated in patients with relapsed/refractory…”
Get full text
Journal Article -
3
Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts
Published in Haematologica (Roma) (01-11-2013)“…The outcome of children and adults with acute lymphoblastic leukemia is markedly different. Since there is limited information on the distribution of…”
Get full text
Journal Article -
4
The Added Value of Multi-State Modelling in Acute Myeloid Leukemia: The Gimema AML1310 Study Post-Hoc Analysis
Published in Blood (15-11-2022)Get full text
Journal Article -
5
Level of activity of neonatal intensive care units and mortality among very preterm infants: a nationwide study in Italy
Published in The journal of maternal-fetal & neonatal medicine (01-12-2012)“…Objectives: To investigate the relationships between mortality of infants <32 weeks gestation and neonatal intensive care units' (NICUs) volume of activity,…”
Get full text
Journal Article -
6
On the Children Side. Overview of 194 Outcomes from Gimema Registry of Conception/Pregnancy in Chronic Myeloid Leukemia (CML)
Published in Blood (02-11-2023)“…Pregnancy in patients with chronic myeloid leukemia (CML) is no longer precluded. The literature published to date has mainly evaluated the management of CML…”
Get full text
Journal Article -
7
Next-Generation Sequencing (NGS) in Childhood Myeloproliferative Diseases (MPD)
Published in Blood (29-11-2018)“…Driver mutations of JAK2, CALR and MPL are found in >90% of adults with BCR-ABL1-negative myeloproliferative neoplasms (MPN). In children, the presence of…”
Get full text
Journal Article -
8
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome
Published in Blood (08-03-2012)“…Sixty-four patients < 20 years of age, investigated for a suspicion of Philadelphia-negative myeloproliferative disease (MPD), were retrospectively evaluated…”
Get full text
Journal Article -
9
Long-Term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib— the Italian Experience
Published in Blood (08-12-2017)“…The availability of imatinib (IM) and thereafter of second-generation tyrosine kinase inhibitors (TKI2) has extended therapeutic options for childhood chronic…”
Get full text
Journal Article -
10
Treatment of Acute Promyelocytic Leukemia
Published in The New England journal of medicine (10-10-2013)“…To the Editor: Lo-Coco et al. (July 11 issue) 1 report that a combination of all- trans retinoic acid (ATRA) and arsenic trioxide as an induction and…”
Get full text
Journal Article -
11
Chlorambucil PLUS Rituximab As FRONT-LINE Therapy for Elderly and/or Unfit CLL Patients. LONG-TERM Follow-up and Correlation with Biologic-Based Risk Stratification
Published in Blood (02-12-2016)“…▪ Introduction. Elderly patients with chronic lymphocytic leukemia (CLL) and younger patients with comorbidities are often treated with chlorambucil (Chl),…”
Get full text
Journal Article -
12
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience
Published in British journal of haematology (01-06-2016)“…Summary We analysed the long‐term outcome of 35 children and adolescents (<20 years at diagnosis) with chronic myeloid leukaemia (CML) in chronic phase: 20…”
Get full text
Journal Article -
13
BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion
Published in Blood (06-12-2014)“…Introduction. Chronic lymphocytic leukemia (CLL) with 11q deletion has been associated to a poor prognosis, but the clinical course of patients carrying this…”
Get full text
Journal Article -
14
Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series
Published in Blood (06-12-2014)“…▪ Background: We recently showed that the combination of ATRA and arsenic trioxide (ATO) is at least not inferior and possibly superior to standard ATRA and…”
Get full text
Journal Article -
15
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Published in The New England journal of medicine (11-07-2013)“…All- trans retinoic acid (ATRA) plus arsenic trioxide was found to be noninferior to ATRA plus chemotherapy, and less toxic, in the treatment of acute…”
Get full text
Journal Article -
16
Fludarabine, Cyclophosphamide and Lenalidomide (FCL) for Previously Treated Patients with Chronic Lymphocytic Leukemia (CLL): Results of the Dose-Finding Phase of the GIMEMA LLC606 Study
Published in Blood (19-11-2010)“…Abstract 1377 Targeting the CLL microenvironment with immunomodulatory agents like lenalidomide results in antileukemic activity. Addition of lenalidomide to…”
Get full text
Journal Article -
17
ATRA and Arsenic Trioxide (ATO) Versus ATRA and Idarubicin (AIDA) for Newly Diagnosed, Non High-Risk Acute Promyelocytic Leukemia (APL): Results of the Phase III, Prospective, Randomized, Intergroup APL0406 Study by the Italian-German Cooperative Groups Gimema-SAL-AMLSG
Published in Blood (16-11-2012)“…Abstract 6 Simultaneous ATRA and chemotherapy (CHT) is the current gold standard for newly diagnosed APL resulting in ∼80% cure rates, while arsenic trioxide…”
Get full text
Journal Article -
18
Clinical and Biological Features, Treatment and Long-Term Outcome of 65 Children with Ph- Myeloprolipherative Disorders (MPD)
Published in Blood (20-11-2009)“…Abstract 1889 Poster Board I-912 MPD rarely occur in children and published data of pediatric patients (pts) are limited. In adults, current diagnostic…”
Get full text
Journal Article -
19
Acute Erythroid Leukemia: A Distinctive Subtype of AML? Outcome and Prognostic Factors in Comparison with Non-M6 AML. The Gimema Experience
Published in Blood (20-11-2009)“…Abstract 1019 Poster Board I-41 Erythroleukemia is characterized by a peculiar marrow feature: a proliferation of erythroblasts greater than 50% and of…”
Get full text
Journal Article